 Jesse Davidson
Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiopulmonary Bypass | 15 | 2025 | 209 | 7.540 |
Why?
| | Heart Defects, Congenital | 12 | 2025 | 830 | 4.020 |
Why?
| | Alkaline Phosphatase | 6 | 2019 | 148 | 2.730 |
Why?
| | Cardiac Surgical Procedures | 8 | 2024 | 531 | 2.550 |
Why?
| | Biomarkers | 11 | 2024 | 4148 | 1.600 |
Why?
| | Postoperative Complications | 9 | 2024 | 2627 | 1.290 |
Why?
| | Infant | 23 | 2025 | 9408 | 1.230 |
Why?
| | Acute Kidney Injury | 3 | 2022 | 807 | 1.220 |
Why?
| | Endothelin-1 | 2 | 2022 | 181 | 1.220 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 2 | 2025 | 25 | 1.110 |
Why?
| | Heart Arrest | 3 | 2020 | 335 | 1.100 |
Why?
| | Kynurenine | 3 | 2024 | 114 | 1.020 |
Why?
| | Tryptophan | 3 | 2024 | 183 | 0.990 |
Why?
| | Infant, Newborn | 14 | 2025 | 6043 | 0.980 |
Why?
| | Swine | 6 | 2025 | 775 | 0.970 |
Why?
| | Adenosine | 2 | 2018 | 227 | 0.960 |
Why?
| | Length of Stay | 6 | 2025 | 1203 | 0.860 |
Why?
| | Prospective Studies | 14 | 2024 | 7543 | 0.860 |
Why?
| | Matrix Metalloproteinase 8 | 1 | 2023 | 8 | 0.850 |
Why?
| | Citrulline | 1 | 2024 | 45 | 0.850 |
Why?
| | Delirium | 1 | 2025 | 85 | 0.840 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 38 | 0.820 |
Why?
| | Arginine | 1 | 2024 | 274 | 0.780 |
Why?
| | Heart Bypass, Right | 1 | 2022 | 17 | 0.760 |
Why?
| | Neurodevelopmental Disorders | 1 | 2025 | 179 | 0.760 |
Why?
| | Oxylipins | 1 | 2022 | 39 | 0.750 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 113 | 0.750 |
Why?
| | Fetal Diseases | 1 | 2023 | 171 | 0.740 |
Why?
| | Amino Acids | 1 | 2025 | 503 | 0.730 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2024 | 290 | 0.700 |
Why?
| | Arrhythmias, Cardiac | 2 | 2020 | 331 | 0.690 |
Why?
| | Heart Diseases | 1 | 2023 | 359 | 0.660 |
Why?
| | Metabolomics | 3 | 2021 | 675 | 0.650 |
Why?
| | Proteome | 1 | 2024 | 473 | 0.650 |
Why?
| | Coronary Care Units | 1 | 2018 | 18 | 0.610 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 1 | 2019 | 27 | 0.610 |
Why?
| | Nitric Oxide | 1 | 2024 | 914 | 0.600 |
Why?
| | Blood Proteins | 1 | 2020 | 250 | 0.600 |
Why?
| | Transcriptome | 1 | 2025 | 973 | 0.590 |
Why?
| | Fontan Procedure | 1 | 2020 | 178 | 0.590 |
Why?
| | Endotoxemia | 1 | 2019 | 86 | 0.580 |
Why?
| | Endotoxins | 1 | 2019 | 220 | 0.570 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2019 | 130 | 0.570 |
Why?
| | Aortic Coarctation | 1 | 2019 | 83 | 0.570 |
Why?
| | 5'-Nucleotidase | 1 | 2018 | 41 | 0.570 |
Why?
| | Ventricular Remodeling | 1 | 2019 | 262 | 0.520 |
Why?
| | Calcitonin | 2 | 2013 | 27 | 0.520 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 595 | 0.520 |
Why?
| | Humans | 35 | 2025 | 136899 | 0.510 |
Why?
| | Postoperative Care | 2 | 2021 | 258 | 0.500 |
Why?
| | Adenosine Monophosphate | 1 | 2016 | 66 | 0.500 |
Why?
| | Protein Precursors | 2 | 2013 | 132 | 0.490 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2018 | 248 | 0.480 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 533 | 0.480 |
Why?
| | Heart Ventricles | 4 | 2024 | 792 | 0.480 |
Why?
| | Ventricular Function, Left | 1 | 2019 | 540 | 0.470 |
Why?
| | Cardiotonic Agents | 2 | 2012 | 126 | 0.460 |
Why?
| | Sepsis | 3 | 2017 | 610 | 0.440 |
Why?
| | C-Reactive Protein | 2 | 2013 | 409 | 0.430 |
Why?
| | Glipizide | 1 | 2013 | 6 | 0.420 |
Why?
| | Octreotide | 1 | 2013 | 26 | 0.420 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2013 | 30 | 0.420 |
Why?
| | Female | 20 | 2025 | 72703 | 0.420 |
Why?
| | Male | 21 | 2025 | 67308 | 0.410 |
Why?
| | Sulfonylurea Compounds | 1 | 2013 | 48 | 0.410 |
Why?
| | Matrix Metalloproteinase 7 | 2 | 2023 | 26 | 0.380 |
Why?
| | Case-Control Studies | 4 | 2024 | 3528 | 0.380 |
Why?
| | Dysbiosis | 2 | 2024 | 179 | 0.380 |
Why?
| | Cardiac Output, Low | 1 | 2012 | 66 | 0.380 |
Why?
| | Lung | 2 | 2022 | 4046 | 0.370 |
Why?
| | Thoracic Surgical Procedures | 1 | 2012 | 73 | 0.370 |
Why?
| | Palliative Care | 3 | 2024 | 737 | 0.360 |
Why?
| | Treatment Outcome | 8 | 2022 | 10768 | 0.350 |
Why?
| | Hypoxia | 3 | 2024 | 1106 | 0.350 |
Why?
| | Purines | 2 | 2022 | 175 | 0.340 |
Why?
| | Heart Failure | 1 | 2024 | 2210 | 0.340 |
Why?
| | Vasodilator Agents | 1 | 2012 | 333 | 0.330 |
Why?
| | Cohort Studies | 4 | 2025 | 5711 | 0.330 |
Why?
| | Child, Preschool | 7 | 2025 | 11013 | 0.320 |
Why?
| | Kinetics | 3 | 2018 | 1679 | 0.300 |
Why?
| | Hypoglycemia | 1 | 2013 | 442 | 0.300 |
Why?
| | Postoperative Period | 2 | 2022 | 344 | 0.290 |
Why?
| | Metabolome | 2 | 2021 | 349 | 0.290 |
Why?
| | Animals | 9 | 2025 | 36915 | 0.280 |
Why?
| | Inflammation | 2 | 2022 | 2817 | 0.270 |
Why?
| | Child | 10 | 2024 | 21896 | 0.270 |
Why?
| | Myocardial Contraction | 2 | 2025 | 343 | 0.240 |
Why?
| | Proteomics | 2 | 2023 | 1111 | 0.240 |
Why?
| | Sphingosine | 1 | 2025 | 46 | 0.230 |
Why?
| | Quality Improvement | 2 | 2025 | 1154 | 0.230 |
Why?
| | Lysophospholipids | 1 | 2025 | 80 | 0.220 |
Why?
| | Mitochondria, Heart | 1 | 2025 | 100 | 0.220 |
Why?
| | Critical Care | 2 | 2021 | 583 | 0.220 |
Why?
| | Fatty Acids, Volatile | 1 | 2024 | 58 | 0.220 |
Why?
| | Organ Specificity | 1 | 2025 | 304 | 0.220 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2025 | 134 | 0.220 |
Why?
| | Language Development | 1 | 2024 | 66 | 0.220 |
Why?
| | Perfusion | 1 | 2025 | 212 | 0.220 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2023 | 26 | 0.210 |
Why?
| | Morbidity | 1 | 2024 | 321 | 0.200 |
Why?
| | Calcitonin Gene-Related Peptide | 2 | 2013 | 40 | 0.200 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 153 | 0.190 |
Why?
| | Serotonin | 2 | 2024 | 324 | 0.190 |
Why?
| | Time Factors | 3 | 2019 | 6802 | 0.190 |
Why?
| | Prostaglandins | 1 | 2022 | 97 | 0.190 |
Why?
| | Analysis of Variance | 2 | 2016 | 1324 | 0.190 |
Why?
| | Models, Animal | 1 | 2023 | 387 | 0.180 |
Why?
| | Niacinamide | 1 | 2021 | 79 | 0.170 |
Why?
| | Methionine | 1 | 2021 | 159 | 0.170 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2030 | 0.170 |
Why?
| | Preoperative Period | 1 | 2020 | 131 | 0.170 |
Why?
| | Heart Function Tests | 1 | 2019 | 61 | 0.160 |
Why?
| | Pulmonary Veins | 1 | 2020 | 99 | 0.160 |
Why?
| | Extracellular Matrix | 1 | 2023 | 526 | 0.160 |
Why?
| | International Classification of Diseases | 1 | 2020 | 131 | 0.160 |
Why?
| | Time | 1 | 2019 | 82 | 0.150 |
Why?
| | Heart Transplantation | 1 | 2025 | 746 | 0.150 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 433 | 0.150 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 256 | 0.150 |
Why?
| | Matrix Metalloproteinases | 1 | 2019 | 94 | 0.150 |
Why?
| | Risk Factors | 4 | 2021 | 10313 | 0.140 |
Why?
| | Rewarming | 1 | 2018 | 20 | 0.140 |
Why?
| | Pilot Projects | 1 | 2023 | 1684 | 0.140 |
Why?
| | GPI-Linked Proteins | 1 | 2018 | 71 | 0.140 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1769 | 0.140 |
Why?
| | Hospitalization | 2 | 2025 | 2183 | 0.140 |
Why?
| | Hospital Mortality | 2 | 2018 | 901 | 0.130 |
Why?
| | Cardiac Catheterization | 1 | 2020 | 528 | 0.130 |
Why?
| | Mass Spectrometry | 1 | 2020 | 741 | 0.130 |
Why?
| | Cognition | 1 | 2025 | 1189 | 0.130 |
Why?
| | Gastrointestinal Microbiome | 1 | 2024 | 689 | 0.130 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2019 | 389 | 0.130 |
Why?
| | Respiration, Artificial | 2 | 2018 | 643 | 0.130 |
Why?
| | Liver | 1 | 2025 | 1937 | 0.130 |
Why?
| | Extracellular Space | 1 | 2016 | 121 | 0.120 |
Why?
| | Solubility | 1 | 2016 | 248 | 0.120 |
Why?
| | Chi-Square Distribution | 1 | 2016 | 533 | 0.120 |
Why?
| | Coronary Thrombosis | 1 | 2015 | 25 | 0.120 |
Why?
| | Age Factors | 2 | 2020 | 3290 | 0.110 |
Why?
| | Cytokines | 1 | 2023 | 2078 | 0.110 |
Why?
| | Intensive Care Units, Pediatric | 2 | 2017 | 229 | 0.110 |
Why?
| | Databases, Factual | 1 | 2020 | 1345 | 0.110 |
Why?
| | Kidney | 1 | 2022 | 1460 | 0.110 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1524 | 0.110 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2015 | 93 | 0.110 |
Why?
| | Cattle | 1 | 2016 | 982 | 0.110 |
Why?
| | Liver Function Tests | 1 | 2013 | 114 | 0.100 |
Why?
| | Prognosis | 2 | 2019 | 4011 | 0.100 |
Why?
| | Intubation | 1 | 2012 | 3 | 0.100 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 434 | 0.100 |
Why?
| | Algorithms | 1 | 2020 | 1695 | 0.100 |
Why?
| | Infusions, Intravenous | 1 | 2013 | 411 | 0.100 |
Why?
| | Logistic Models | 2 | 2020 | 2060 | 0.090 |
Why?
| | Linear Models | 1 | 2013 | 850 | 0.090 |
Why?
| | Adolescent | 5 | 2024 | 21402 | 0.080 |
Why?
| | ROC Curve | 1 | 2012 | 543 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2021 | 15514 | 0.080 |
Why?
| | Intubation, Intratracheal | 1 | 2012 | 259 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2833 | 0.080 |
Why?
| | Risk Assessment | 1 | 2018 | 3432 | 0.080 |
Why?
| | Myocardial Infarction | 1 | 2015 | 1044 | 0.070 |
Why?
| | Food Intolerance | 1 | 2024 | 3 | 0.060 |
Why?
| | Kynurenic Acid | 1 | 2024 | 20 | 0.060 |
Why?
| | Citalopram | 1 | 2020 | 32 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 59 | 0.040 |
Why?
| | Intestinal Mucosa | 1 | 2024 | 608 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 84 | 0.040 |
Why?
| | Odds Ratio | 1 | 2020 | 1063 | 0.030 |
Why?
| | Adult | 1 | 2020 | 37595 | 0.030 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2019 | 236 | 0.030 |
Why?
| | Vasoconstrictor Agents | 1 | 2017 | 137 | 0.030 |
Why?
| | Survival Rate | 1 | 2021 | 1972 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 795 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 59 | 0.030 |
Why?
| | Subtilisins | 1 | 1994 | 10 | 0.030 |
Why?
| | Hemodynamics | 1 | 2019 | 1114 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4281 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1240 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2783 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1994 | 100 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 5766 | 0.030 |
Why?
| | Lysosomes | 1 | 1994 | 142 | 0.030 |
Why?
| | Endosomes | 1 | 1994 | 136 | 0.030 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 225 | 0.030 |
Why?
| | Blood Pressure | 1 | 2019 | 1774 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 271 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 1994 | 501 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 454 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2015 | 1417 | 0.020 |
Why?
| | Mice | 1 | 2025 | 17775 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3710 | 0.020 |
Why?
| | United States | 1 | 2021 | 14595 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 13157 | 0.010 |
Why?
| | Immunologic Techniques | 1 | 1994 | 40 | 0.010 |
Why?
| | Furin | 1 | 1994 | 14 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1994 | 52 | 0.010 |
Why?
| | Cytoplasm | 1 | 1994 | 274 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1994 | 2143 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1994 | 2901 | 0.010 |
Why?
| | Cell Line | 1 | 1994 | 2847 | 0.000 |
Why?
| | Rats | 1 | 1994 | 5675 | 0.000 |
Why?
|
|
Davidson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|